Publication | Open Access

CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute

Cell RegulationGenetic InactivationProteomic AnalysesMedicineCancer Cell BiologyCell LinesCancer GenomicsCancer BiologyCell BiologyCancer GeneticsOncologyRadiation OncologyCancer ResearchTumor Biology